Machine Learning-Assisted Recurrence Prediction for Early-Stage Non-Small-Cell Lung Cancer Patients
Authors:
Adrianna Janik,
Maria Torrente,
Luca Costabello,
Virginia Calvo,
Brian Walsh,
Carlos Camps,
Sameh K. Mohamed,
Ana L. Ortega,
Vít Nováček,
Bartomeu Massutí,
Pasquale Minervini,
M. Rosario Garcia Campelo,
Edel del Barco,
Joaquim Bosch-Barrera,
Ernestina Menasalvas,
Mohan Timilsina,
Mariano Provencio
Abstract:
Background: Stratifying cancer patients according to risk of relapse can personalize their care. In this work, we provide an answer to the following research question: How to utilize machine learning to estimate probability of relapse in early-stage non-small-cell lung cancer patients?
Methods: For predicting relapse in 1,387 early-stage (I-II), non-small-cell lung cancer (NSCLC) patients from t…
▽ More
Background: Stratifying cancer patients according to risk of relapse can personalize their care. In this work, we provide an answer to the following research question: How to utilize machine learning to estimate probability of relapse in early-stage non-small-cell lung cancer patients?
Methods: For predicting relapse in 1,387 early-stage (I-II), non-small-cell lung cancer (NSCLC) patients from the Spanish Lung Cancer Group data (65.7 average age, 24.8% females, 75.2% males) we train tabular and graph machine learning models. We generate automatic explanations for the predictions of such models. For models trained on tabular data, we adopt SHAP local explanations to gauge how each patient feature contributes to the predicted outcome. We explain graph machine learning predictions with an example-based method that highlights influential past patients. Results: Machine learning models trained on tabular data exhibit a 76% accuracy for the Random Forest model at predicting relapse evaluated with a 10-fold cross-validation (model was trained 10 times with different independent sets of patients in test, train and validation sets, the reported metrics are averaged over these 10 test sets). Graph machine learning reaches 68% accuracy over a 200-patient, held-out test set, calibrated on a held-out set of 100 patients. Conclusions: Our results show that machine learning models trained on tabular and graph data can enable objective, personalised and reproducible prediction of relapse and therefore, disease outcome in patients with early-stage NSCLC. With further prospective and multisite validation, and additional radiological and molecular data, this prognostic model could potentially serve as a predictive decision support tool for deciding the use of adjuvant treatments in early-stage lung cancer. Keywords: Non-Small-Cell Lung Cancer, Tumor Recurrence Prediction, Machine Learning
△ Less
Submitted 17 November, 2022;
originally announced November 2022.
IASIS and BigMedilytics: Towards personalized medicine in Europe
Authors:
Ernestina Menasalvas Ruiz,
Alejandro Rodríguez-González,
Consuelo Gonzalo Martín,
Massimiliano Zanin,
Juan Manuel Tuñas,
Mariano Provencio,
Maria Torrente,
Fabio Franco,
Virginia Calvo,
Beatriz Nuñez
Abstract:
One field of application of Big Data and Artificial Intelligence that is receiving increasing attention is the biomedical domain. The huge volume of data that is customary generated by hospitals and pharmaceutical companies all over the world could potentially enable a plethora of new applications. Yet, due to the complexity of such data, this comes at a high cost. We here review the activities of…
▽ More
One field of application of Big Data and Artificial Intelligence that is receiving increasing attention is the biomedical domain. The huge volume of data that is customary generated by hospitals and pharmaceutical companies all over the world could potentially enable a plethora of new applications. Yet, due to the complexity of such data, this comes at a high cost. We here review the activities of the research group composed by people of the Universidad Politécnica de Madrid and the Hospital Universitario Puerta de Hierro de Majadahonda, Spain; discuss their activities within two European projects, IASIS and BigMedilytics; and present some initial results.
△ Less
Submitted 20 September, 2018;
originally announced September 2018.
